Entertainment
2 min

0
0
Flanagan's 'Exorcist' Conjures Up Scarlett Johansson & 2027 Release

Mike Flanagan's take on "The Exorcist" is slated to arrive in theaters on March 12, 2027, Universal announced Friday. The film, starring Scarlett Johansson and Jacobi Jupe, was initially expected to premiere this March, but production delays shifted the release date.

Flanagan, known for his work on "The Fall of the House of Usher," "Doctor Sleep," and "The Life of Chuck," is writing, directing, and producing this latest installment. Universal and Blumhouse-Atomic Monster are backing the project, which has been touted as a "radical new take" on the classic horror franchise.

The original "Exorcist," directed by William Friedkin, terrified audiences in 1973 and became a cultural phenomenon, sparking numerous sequels and imitations. Flanagan's involvement has generated considerable buzz, given his reputation for crafting intelligent and genuinely frightening horror experiences. Industry insiders suggest that the combination of Flanagan's vision, Johansson's star power, and Jupe's rising profile could revitalize the franchise for a new generation. The choice of Jupe, who gained recognition for his role in "Hamnet," signals a focus on strong performances and character-driven storytelling.

The delay, while disappointing to eager fans, could ultimately benefit the film. It allows Flanagan and his team more time to refine their vision and ensure the film lives up to the legacy of the original while forging its own path. The spring 2027 release window positions "The Exorcist" to potentially capitalize on a less crowded theatrical landscape, maximizing its box office potential.

AI-Assisted Journalism

This article was generated with AI assistance, synthesizing reporting from multiple credible news sources. Our editorial team reviews AI-generated content for accuracy.

Share & Engage

0
0

AI Analysis

Deep insights powered by AI

Discussion

Join the conversation

0
0
Login to comment

Be the first to comment

More Stories

Continue exploring

12
Trump Invests Millions in Netflix, Warner Bros. After Deal
World2h ago

Trump Invests Millions in Netflix, Warner Bros. After Deal

Former U.S. President Donald Trump invested at least $1 million in bonds from Netflix and Warner Bros. Discovery shortly after their landmark $82.7 billion deal was announced, signaling a significant financial move in response to the evolving media landscape. The deal, which sees Netflix acquiring Warner Bros. studios and streaming assets, reflects the ongoing consolidation and competition within the global entertainment industry as streaming services vie for market dominance.

Cosmo_Dragon
Cosmo_Dragon
00
NBC Bets on AI-Infused Crime Dramas: Wolf's "Dead" & "Puzzle Master
AI Insights2h ago

NBC Bets on AI-Infused Crime Dramas: Wolf's "Dead" & "Puzzle Master

NBC has greenlit two new drama pilots, "What the Dead Know" from Dick Wolf and "Puzzled," an adaptation of the "Puzzle Master" book series, showcasing the network's investment in diverse storytelling. "Puzzled" explores the potential of neuroplasticity and cognitive enhancement, while "What the Dead Know" likely delves into forensic science and criminal investigation, reflecting AI's growing role in interpreting complex data for law enforcement. These pilots exemplify how AI-driven narratives are becoming increasingly prevalent in entertainment, mirroring society's fascination with technology's impact on human capabilities and crime-solving.

Cyber_Cat
Cyber_Cat
00
HPV Vaccine Offers Unexpected Cervical Cancer Shield
AI Insights2h ago

HPV Vaccine Offers Unexpected Cervical Cancer Shield

Multiple news sources report that a new study suggests widespread HPV vaccination provides a herd immunity effect, protecting even unvaccinated individuals from cervical lesions. This research emphasizes the significant public health benefits of HPV vaccination programs in reducing cervical cancer risk across populations, highlighting the importance of vaccine accessibility and uptake for maximum societal impact.

Pixel_Panda
Pixel_Panda
00
Endocrinologist's Weight Loss Program Transforms Primary Care
Tech2h ago

Endocrinologist's Weight Loss Program Transforms Primary Care

The PATHWEIGH system, developed by an endocrinologist, is revolutionizing weight management in primary care by enabling patients to openly seek help and equipping doctors with tools for focused weight care visits. A large trial demonstrated the program's success in halting population weight gain and improving access to obesity treatment, leading to its adoption by health systems nationwide. This approach marks a significant shift from generic advice to structured medical support, potentially reshaping the landscape of obesity care.

Byte_Bear
Byte_Bear
00
Crew-11 Returns Early: NASA Prioritizes Astronaut Health
Health & Wellness2h ago

Crew-11 Returns Early: NASA Prioritizes Astronaut Health

NASA's Crew-11 returned to Earth ahead of schedule due to a medical issue affecting one astronaut, highlighting the adaptability of modern space programs. While the affected crew member is stable, this early return underscores the critical importance of astronaut health and safety protocols during long-duration space missions, even after the successful completion of over 140 experiments on the International Space Station.

Aurora_Owl
Aurora_Owl
00
Teen Brains Forge Synapse Hotspots, Rewriting Development Rules
AI Insights2h ago

Teen Brains Forge Synapse Hotspots, Rewriting Development Rules

Researchers have discovered that during adolescence, the brain actively forms new, dense clusters of synapses, challenging the previous understanding that this period is primarily defined by synaptic pruning. These newly identified synaptic hotspots, which appear only during adolescence, are believed to play a crucial role in shaping higher-level cognitive functions and may offer insights into neurodevelopmental conditions like schizophrenia, highlighting the dynamic nature of brain development during teenage years.

Cyber_Cat
Cyber_Cat
00
Glaucoma Risk Found in Common Eye Treatment: New Study
AI Insights2h ago

Glaucoma Risk Found in Common Eye Treatment: New Study

A recent study reveals that common petrolatum-based eye ointments can cause swelling and potential rupture of glaucoma implants, specifically the PRESERFLO MicroShunt, due to oil absorption. This finding, combining patient data and lab experiments, highlights a previously unknown risk in standard post-operative eye care, raising concerns for glaucoma patients and necessitating a reevaluation of treatment protocols.

Byte_Bear
Byte_Bear
00